Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mepolizumab Effectiveness and Allergic Status in Real Life.
Sposato B, Scalese M, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Corsico A, Grosso A, Baglioni S, Murgia N, Folletti I, Pelaia G, Masieri S, Cavaliere C, Musarra A, Bargagli E, Ricci A, Latorre M, Paggiaro P, Rogliani P. Sposato B, et al. Among authors: bargagli e. Int Arch Allergy Immunol. 2021;182(4):311-318. doi: 10.1159/000511147. Epub 2020 Oct 28. Int Arch Allergy Immunol. 2021. PMID: 33113532
Immunoglobulin replacement therapy for yellow nail syndrome.
Lo Conte C, Allegrini C, Matucci A, Bartolucci M, Rosi E, Camiciottoli G, Amendola M, Pistolesi M, Bargagli E. Lo Conte C, et al. Among authors: bargagli e. Scand J Immunol. 2018 Mar;87(3). doi: 10.1111/sji.12639. Epub 2018 Jan 10. Scand J Immunol. 2018. PMID: 29280506 Free article. No abstract available.
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes.
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Ricci A, Cresti A, Santus P, Olivieri C, Perrella A, Rogliani P, Paggiaro P; Omalizumab Italian Study Group. Sposato B, et al. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1643-1646. doi: 10.1016/j.jaip.2019.03.006. Epub 2019 Mar 19. J Allergy Clin Immunol Pract. 2019. PMID: 30898690 No abstract available.
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life.
Sposato B, Camiciottoli G, Bacci E, Scalese M, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Masieri S, Corsico A, Scichilone N, Baglioni S, Murgia N, Folletti I, Bardi G, Grosso A, Cameli P, Latorre M, Musarra A, Bargagli E, Ricci A, Pelaia G, Paggiaro P, Rogliani P. Sposato B, et al. Among authors: bargagli e. Pulm Pharmacol Ther. 2020 Apr;61:101899. doi: 10.1016/j.pupt.2020.101899. Epub 2020 Jan 21. Pulm Pharmacol Ther. 2020. PMID: 31972327
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting.
Cameli P, Bergantini L, d'Alessandro M, Perruzza M, Cekorja B, Perillo F, Massa E, Ruzza A, Fossi A, Beltrami V, Sestini P, Bargagli E. Cameli P, et al. Among authors: bargagli e. Int Arch Allergy Immunol. 2020;181(8):606-612. doi: 10.1159/000507996. Epub 2020 Jun 9. Int Arch Allergy Immunol. 2020. PMID: 32516771
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis.
Sposato B, Scalese M, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Corsico A, Grosso A, Baglioni S, Murgia N, Folletti I, Pelaia G, Masieri S, Cavaliere C, Musarra A, Bargagli E, Ricci A, Latorre M, Rogliani P, Paggiaro P. Sposato B, et al. Among authors: bargagli e. Respir Med Res. 2020 Nov;78:100791. doi: 10.1016/j.resmer.2020.100791. Epub 2020 Sep 21. Respir Med Res. 2020. PMID: 33039948 No abstract available.
307 results